• Citer

Association of T-Cell Receptor Repertoire Use With Response to Combined Trastuzumab-Lapatinib Treatment of HER2-Positive Breast Cancer: Secondary Analysis of the NeoALTTO Randomized Clinical Trial.

par Powles, Ryan L;Redmond, David;Sotiriou, Christos ;Loi, Sherene ;Fumagalli, Debora ;Nuciforo, Paolo;Harbeck, Nadia;De Azambuja, Evandro ;Sarp, Severine;Di Cosimo, Serena;Huober, Jens;Baselga, José;Piccart-Gebhart, Martine ;Elemento, Olivier;Pusztai, Lajos;Hatzis, Christos
Référence JAMA oncology, page (e181564)
Publication Publié, 2018-06

Article révisé par les pairs

• Détails
• Contenu

Titre:	Association of T-Cell Receptor Repertoire Use With Response to Combined Trastuzumab-Lapatinib Treatment of HER2-Positive Breast Cancer: Secondary Analysis of the NeoALTTO Randomized Clinical Trial.
Auteur:	Powles, Ryan L; Redmond, David; Sotiriou, Christos; Loi, Sherene; Fumagalli, Debora; Nuciforo, Paolo; Harbeck, Nadia; De Azambuja, Evandro; Sarp, Severine; Di Cosimo, Serena; Huober, Jens; Baselga, José; Piccart-Gebhart, Martine; Elemento, Olivier; Pusztai, Lajos; Hatzis, Christos
Informations sur la publication:	JAMA oncology, page (e181564)
Statut de publication:	Publié, 2018-06
Sujet CREF:	Cancérologie
	Médecine pathologie humaine
	Sciences bio-médicales et agricoles
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:2374-2437
	info:doi/10.1001/jamaoncol.2018.1564
	info:pii/2684627
	info:scp/85056424144
	info:pmid/29902299
	PMC6224305